2 Your Health: How Super Bowl stress can affect your heart
Super Bowl Sunday is almost here, and football fans are gearing up for the big game. But all the ups and downs that come with cheering on your favorite team can take a toll on the heart.
'The reason is that the emotional stress of watching the game can trigger surges of adrenaline. In turn, this can elevate blood pressure, increase your heart rate, and even provoke dangerous heart rhythms–particularly in those with an underlying cardiovascular disease,' explained Nicholas Ruthmann, MD, a cardiologist.
Dr. Ruthmann said it's well-documented that major sporting events can increase the risk of heart attacks. Along with the game-day stress, what we eat and drink can also contribute to this increased risk.
That's because enjoying too many of those tasty Super Bowl treats and cocktails can put even more strain on the heart. When it comes to reducing your risk, Dr. Ruthmann said moderation is key and even recommends taking a break from the game if you get too stressed out.
Above all, it's important to get medical help right away if you're having symptoms of a heart attack.
'Don't wait for the fourth quarter if you're having signs or symptoms of a heart attack. Pay attention to what's happening with your body during the event and seek medical care quickly,' Dr. Ruthmann said.
Although those with underlying health conditions are at a higher risk, Dr. Ruthmann said anyone can experience a heart attack and stresses not to ignore any sort of chest pain or shortness of breath.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
6 hours ago
- Business Insider
An OpenAI exec says she was diagnosed with breast cancer and that ChatGPT has helped her navigate it
Kate Rouch, the chief marketing officer at OpenAI, shared on Friday that she was diagnosed with invasive breast cancer weeks after assuming the role, which she called her "dream job," in December. In a thread posted on X, Rouch said she was sharing her story to help other women, adding, "We can't control what happens to us--but we can choose how we face it. My biggest lesson: no one fights alone." Prior to joining OpenAI as the company's first CMO, Rouch was CMO at Coinbase and, before that, spent over a decade at Meta, including as vice president, global head of brand and product marketing. Rouch said she started treatment right around the Super Bowl in February, when OpenAI aired its first-ever ad, and that she has since gone through 13 rounds of chemotherapy while leading OpenAI's marketing team. She wrote that she is expected to make a full recovery. "It has been the hardest season of life — for me, for my husband, and for our two young children," Rouch said, adding she has been supported by OpenAI "at every step." "Silicon Valley can be brutal and transactional. And yet — I've never felt more held," she said, adding that "people showed up in incredible and unexpected ways." Rouch also said OpenAI's ChatGPT has helped her navigate her diagnosis and treatment, including by explaining cancer in a way that is age-appropriate for her kids, helping her manage the side effects of chemo, and creating custom meditations. "Experiencing our work as a patient has made OpenAI's mission feel more personal and important," she said. Rouch said she was sharing her story to encourage other women to "prioritize their health over the demands of families and jobs." "A routine exam saved my life. It could save yours, too," she said. Business Insider reached out to OpenAI for comment. Kevin Weil, the chief product officer at OpenAI, expressed support for Rouch in a reply to her thread. "We love you @kate_rouch!" he wrote. "Proud of you for telling your story and for being so full of fight."
Yahoo
6 hours ago
- Yahoo
H.C. Wainwright Initiates Coverage of Akebia Therapeutics (AKBA) With Buy Rating
Matthew Caufield, an analyst from H.C. Wainwright, initiated coverage of Akebia Therapeutics, Inc. (NASDAQ:AKBA) with a Buy rating and a $8 price target, on June 4. The analyst gave the optimistic rating due to the company's VAFSEO product and its potential in the CKD anemia market. VAFSEO is an approved treatment for anemia in adults with chronic kidney disease on dialysis. According to the analyst, the treatment is gaining considerable momentum among dialysis organizations, and this trend is anticipated to support near-term growth. He expects VAFSEO's ongoing launch to offset the effect of generics on AURYXIA, another product by Akebia Therapeutics, Inc. (NASDAQ:AKBA) that deals with hyperphosphatemia. A biopharmaceutical team in a laboratory analyzing new compounds to develop therapeutics. The analyst also reasoned that Akebia Therapeutics, Inc. (NASDAQ:AKBA) is positioned for success as it has secured contracts that cover almost all dialysis patients in the US. VAFSEO offers flexibility in its dosing regimen, ranging from 150mg to 600mg, making it a factor that allows for personalized treatment and potentially growing prescriptions. Caufield pointed out VAFSEO's oral administration as another reason supporting the optimistic rating, giving it an advantage over existing therapies, such as iron supplementation and erythropoiesis-stimulating agents. Akebia Therapeutics, Inc. (NASDAQ:AKBA) is a biopharmaceutical company that develops and commercializes drugs to treat metabolic and renal diseases. While we acknowledge the potential of AKBA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Sign in to access your portfolio
Yahoo
7 hours ago
- Yahoo
Uptick in tick bites reported in Central Pennsylvania emergency rooms
JOHNSTOWN, Pa. (WTAJ) — With summer temperatures reaching Central Pennsylvania, emergency rooms are noticing an uptick in ticks. 'The seasons are now changing and so we're doing a lot more outdoor stuff,' said Nsikak Daniel, M.D., an emergency room physician at Conemaugh Memorial Medical Center in Johnstown. 'Ticks are just one of those things you kind of get when you go out into the woods.' While children and older adults may have the most adverse reactions to tick bites, everyone should take precautions. Juniata College receives approval from state nursing board for new nursing program 'Wear clothing that covers you up, you know, socks and stuff like that with your shoes. Insect repellents sometimes can help,' Daniels said. Lyme Disease is a common illness carried by ticks, often characterized by a bullseye–shaped rash around a bite. While it's become more prevalent, Daniels said it's not the only thing you should worry about. 'One of the complications a lot of people don't think about is something that's called anaplasmosis. It's a very serious, tick borne illness and it's something that can affect your bloodstream. It can affect your organs and cause organ damage,' Daniels said. If you get bit and have any concerns that you did not remove the tick or notice signs of infection such as fever or a rash, you should go to the emergency room immediately. Veterinarians also said they're seeing a rise in bites and infections in dogs. They said the best way to keep your furry friend safe is to use medications and repellents, mow your lawn and avoid high risk areas like tall grass and wooded areas during tick season. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
